Heiko Walch

Title: Heiko Walch: Innovator in Glycoengineering

Introduction

Heiko Walch is a notable inventor based in Penzberg, Germany. He has made significant contributions to the field of glycoengineering, particularly in the modification of antibodies. With a total of 2 patents, his work has implications for therapeutic antibody development.

Latest Patents

Heiko Walch's latest patents include innovative methods for the enzymatic preparation of antibodies with modified glycosylation in the Fc-region. One patent details a method for the re-use of enzymes in in vitro glycoengineering of antibodies. This method involves incubating an antibody with specific enzymes to modify its glycosylation, followed by chromatography steps to separate the modified antibody from the enzymes. Another patent outlines a method for in vitro glycoengineering that includes incubating a monoclonal antibody with enzymes to achieve a defined glycosylation form, followed by recovery and separation processes.

Career Highlights

Throughout his career, Heiko Walch has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative techniques in glycoengineering.

Collaborations

Heiko has collaborated with notable professionals in his field, including Roberto Falkenstein and Sebastian Malik. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Heiko Walch's contributions to glycoengineering through his patents and collaborations highlight his role as an influential inventor in the field. His innovative methods for modifying antibodies have the potential to enhance therapeutic applications significantly.